1000-467X
2016 Issue 5
..............page:204
Cell-free circulating tumor DNA in cancer
Zhen Qin;Vladimir A.Ljubimov;Cuiqi Zhou;Yunguang Tong;Jimin Liang;Department of Medicine;Cedars-Sinai Medical Center;David Geffen School of Medicine at UCLA;School of Life Science and Technology;Xidian University;Keck School of Medicine;University of Southern California;Department of Pathology;Xinxiang Medical University;
Zhen Qin;Vladimir A.Ljubimov;Cuiqi Zhou;Yunguang Tong;Jimin Liang;Department of Medicine;Cedars-Sinai Medical Center;David Geffen School of Medicine at UCLA;School of Life Science and Technology;Xidian University;Keck School of Medicine;University of Southern California;Department of Pathology;Xinxiang Medical University;
..............page:205-213
Altered expression of stromal interaction molecule（STIM）-calcium release-activated calcium channel protein（ORAI） and inositol1,4,5-trisphosphate receptors（IP3Rs）in cancer:will they become a new battlefield for oncotherapy?
Jing Wen;Ying-Cheng Huang;Huan-Huan Xiu;Zhi-Ming Shan;Kang-Qing Xu;Department of Anesthesiology;The First Affiliated Hospital;Sun Yat-sen University;Zhongshan School of Medicine;Sun Yat-sen University;
Jing Wen;Ying-Cheng Huang;Huan-Huan Xiu;Zhi-Ming Shan;Kang-Qing Xu;Department of Anesthesiology;The First Affiliated Hospital;Sun Yat-sen University;Zhongshan School of Medicine;Sun Yat-sen University;
..............page:214-222
A multicenter,retrospective.epidemiologic survey of the clinical features and management of bone metastatic disease in China
Yunpeng Yang;Yuxiang Ma;Jin Sheng;Yan Huang;Yuanyuan Zhao;Wenfeng Fang;Shaodong Hong;Ying Tian;Cong Xue;Li Zhang;Department of Medical Oncology;Sun Yat-sen University Cancer Center;State Key Laboratory of Oncology in South China;Collaborative Innovation Center for Cancer Medicine;
Yunpeng Yang;Yuxiang Ma;Jin Sheng;Yan Huang;Yuanyuan Zhao;Wenfeng Fang;Shaodong Hong;Ying Tian;Cong Xue;Li Zhang;Department of Medical Oncology;Sun Yat-sen University Cancer Center;State Key Laboratory of Oncology in South China;Collaborative Innovation Center for Cancer Medicine;
..............page:223-228
Prospective,single-center cohort studyanalyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma
Jie Zhang;Zhong-Guo Zhou;Zhong-Xi Huang;Ke-Li Yang;Jian-Cong Chen;Jin-Bin Chen;Li Xu;Min-Shan Chen;Yao-Jun Zhang;Department of Hepatobiliary Oncology;Sun Yat-sen University Cancer Center;State Key Laboratory of Oncology in South China;Collaborative Innovation Center for Cancer Medicine;
Jie Zhang;Zhong-Guo Zhou;Zhong-Xi Huang;Ke-Li Yang;Jian-Cong Chen;Jin-Bin Chen;Li Xu;Min-Shan Chen;Yao-Jun Zhang;Department of Hepatobiliary Oncology;Sun Yat-sen University Cancer Center;State Key Laboratory of Oncology in South China;Collaborative Innovation Center for Cancer Medicine;
..............page:229-235
Association of HBV DNA replication.with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
Jian-Lin Chen;Xiao-Jun Lin;Qian Zhou;Ming Shi;Sheng-Ping Li;Xiang-Ming Lao;Department of Hepatobiliary Oncology;State Key Laboratory of Southern China;Collaborative Innovation Center for Cancer Medicine;Sun Yat-sen University Cancer Center;Epidemiology Research Unit;The First Affiliated Hospital of Sun Yat-sen University;
Jian-Lin Chen;Xiao-Jun Lin;Qian Zhou;Ming Shi;Sheng-Ping Li;Xiang-Ming Lao;Department of Hepatobiliary Oncology;State Key Laboratory of Southern China;Collaborative Innovation Center for Cancer Medicine;Sun Yat-sen University Cancer Center;Epidemiology Research Unit;The First Affiliated Hospital of Sun Yat-sen University;
..............page:236-249
Effect of preoperative injection of carbon nanoparticle suspension on the outcomes of selected patients with mid-low rectal cancer
Xing-Mao Zhang;Jian-Wei Liang;Zheng Wang;Jian-tao Kou;Zhi-Xiang Zhou;Department of Hepatobiliary Surgery;Beijing Chaoyang Hospital;Capital Medical University;Department of Gastrointestinal Surgery;Cancer Hospital;Chinese Academy of Medical Sciences & Peking Union Medical College;
Xing-Mao Zhang;Jian-Wei Liang;Zheng Wang;Jian-tao Kou;Zhi-Xiang Zhou;Department of Hepatobiliary Surgery;Beijing Chaoyang Hospital;Capital Medical University;Department of Gastrointestinal Surgery;Cancer Hospital;Chinese Academy of Medical Sciences & Peking Union Medical College;
..............page:250-254
Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma
Shao-Qing Niu;Yong Yang;Yi-Yang Li;Ge Wen;Liang Wang;Zhi-Ming Li;Han-Yu Wang;Lu-Lu Zhang;Yun-Fei Xia;Yu-Jing Zhang;State Key Laboratory of Oncology in South China;Collaborative Innovation Center for Cancer Medicine;Sun Yat-sen University Cancer Center;Department of Radiation Oncology;Sun Yat-sen University Cancer Center;Department of Radiation Oncology;The First Affiliated Hospital of Sun Yat-sen University;Department of Radiation Oncology;Cancer Hospital and Institute;Peking Union Medical College and Chinese Academy of Medical Sciences;Department of Nuclear Medicine;The Third Affiliated Hospital of Guangzhou Medical University;Department of Hematological Oncology;Sun Yatsen University Cancer Center;Department of Medical Oncology;Sun Yat-sen University Cancer Center;
Shao-Qing Niu;Yong Yang;Yi-Yang Li;Ge Wen;Liang Wang;Zhi-Ming Li;Han-Yu Wang;Lu-Lu Zhang;Yun-Fei Xia;Yu-Jing Zhang;State Key Laboratory of Oncology in South China;Collaborative Innovation Center for Cancer Medicine;Sun Yat-sen University Cancer Center;Department of Radiation Oncology;Sun Yat-sen University Cancer Center;Department of Radiation Oncology;The First Affiliated Hospital of Sun Yat-sen University;Department of Radiation Oncology;Cancer Hospital and Institute;Peking Union Medical College and Chinese Academy of Medical Sciences;Department of Nuclear Medicine;The Third Affiliated Hospital of Guangzhou Medical University;Department of Hematological Oncology;Sun Yatsen University Cancer Center;Department of Medical Oncology;Sun Yat-sen University Cancer Center;
..............page:255-263
Does adding intraperitoneal paclitaxel to standard intraperitoneal regimen yield incremental survival? A propensity score-matched cohort study
Yen-Hou Chang;Chien-Hsing Lu;Ming-Shyen Yen;Wai-Hou Lee;Yi Chang;Wei-Pin Chang;Chi-Mu Chuang;Institute of Clinical Medicine;School of Medicine;National Yang-Ming University;Department of Obstetrics and Gynecology;Taipei Veterans General Hospital;Department of Obstetrics and Gynecology;Taichung Veterans General Hospital;Institute of Biomedical Sciences;National Chung Hsing University;Rong-Hsing Research Center forTranslational Medicine;National Chung Hsing University;Department of Healthcare Management;Yuanpei University;
Yen-Hou Chang;Chien-Hsing Lu;Ming-Shyen Yen;Wai-Hou Lee;Yi Chang;Wei-Pin Chang;Chi-Mu Chuang;Institute of Clinical Medicine;School of Medicine;National Yang-Ming University;Department of Obstetrics and Gynecology;Taipei Veterans General Hospital;Department of Obstetrics and Gynecology;Taichung Veterans General Hospital;Institute of Biomedical Sciences;National Chung Hsing University;Rong-Hsing Research Center forTranslational Medicine;National Chung Hsing University;Department of Healthcare Management;Yuanpei University;
..............page:264-267
..............page:268